Aurinia Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Edmonton, Alberta, Canada
SEC filing record 1 source field available
Fiscal year end
31 December
Aurinia Pharmaceuticals Inc. has filed 606 SEC EDGAR filings since 28 Feb 2014

SEC filing history

Showing 451-475 of 606 matching filings.

Per page
25
Current page
19
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
19 Sep 2017
Reporting date
19 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
05 Sep 2017
Reporting date
05 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

FORM 6-K

Filing date
10 Aug 2017
Reporting date
10 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
10 Aug 2017
Reporting date
10 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
13 Jul 2017
Reporting date
12 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88628

SC 13G

Filing date
05 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
22 Jun 2017
Reporting date
22 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
16 Jun 2017
Reporting date
16 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
05 Jun 2017
Reporting date
05 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
24 May 2017
Reporting date
17 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

6-K

Filing date
19 May 2017
Reporting date
19 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

FORM 6-K

Filing date
15 May 2017
Reporting date
15 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
15 May 2017
Reporting date
15 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
15 May 2017
Reporting date
08 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
04 May 2017
Reporting date
26 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-88628

THE SCHEDULE 13D

Filing date
01 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
20 Apr 2017
Reporting date
20 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
20 Apr 2017
Reporting date
17 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
17 Apr 2017
Reporting date
10 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88628

SC 13G

Filing date
06 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
06 Apr 2017
Reporting date
06 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
27 Mar 2017
Reporting date
27 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88628

SC 13D/A

Filing date
27 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
23 Mar 2017
Reporting date
23 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
20 Mar 2017
Reporting date
20 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .